We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recombinant Interferon-Alpha-2C in Laryngeal Papillomatosis: Preliminary Results of a Prospective Multicentre Trial.
- Authors
Zenner, H.P.; Kley, W.; Clarós, P.; Clarós, A.; Labas, Z.; Löbe, L.P.; Pavelka, R.; Plath, P.; Ribari, O.; Niethammer, D.; Hirche, H.
- Abstract
A preparation of interferon-α2c of high purity formed by recombinant DNA technology was used as adjuvant therapy following removal of laryngeal papillomas by cauterization or laser vapourization. Preliminary data on 20 patients are reported and include 11 complete and 7 partial responses. Side-effects included initial temperature elevation, but this subsided and other side-effects were uncommon. No antibodies to the interferon preparation were found in any of the patients. Copyright © 1985 S. Karger AG, Basel
- Publication
Oncology, 1985, Vol 42, Issue S1, p15
- ISSN
0030-2414
- Publication type
Article
- DOI
10.1159/000226079